青年乳腺癌患者心理韧性、焦虑及抑郁的影响因素分析

Analysis of influencing factors of psychological resilience,anxiety and depression in young patients with breast cancer

目的分析青年乳腺癌患者心理韧性、焦虑及抑郁的影响因素。方法选取2015年6月至2018年6月本院收治的162例青年乳腺癌患者为研究对象,比较所有患者焦虑自评量表(self-rating anxiety scale,SAS)、抑郁自评量表(self-rating depression scale,SDS)及Connor-Davidson心理韧性量表(Connor-Davidson resilience scale,CD-RISC)结果,并采用单因素χ2检验和多因素Logistic回归分析探讨青年乳腺癌患者焦虑、抑郁及心理韧性的影响因素。结果有不良反应的乳腺癌患者焦虑、抑郁及心理韧性水平低的发生风险均显著高于无不良反应者(焦虑:OR=28.723;抑郁:OR=23.954;心理韧性水平低:OR=52.543);希望得到医生支持的患者较希望得到亲属支持的患者更容易出现焦虑状态(OR=257.035);医生重视程度一般、无乳腺癌家族史的患者较医生很重视、有乳腺癌家族史的患者抑郁的发生风险更高(OR=9.310、422.570)。结论青年乳腺癌患者普遍存在焦虑、抑郁的不良心理,且心理韧性水平较低,临床治疗中需要加强对患者的健康教育和心理干预,降低不良反应发生率,给予其社会支持,以减少青年乳腺癌患者的不良心理问题。

Objective To explore the influencing factors of psychological resilience, anxiety and depression in young patients with breast cancer. Method 162 young breast cancer patients admitted to our hospital from June 2015 to June 2018 were selected as subjects. All patients were compared with self-rating anxiety scale （SAS）, self-rating depression scale （SDS） and Colnnor-Davidson resilience scale （CD-RISC） results, and used single factor χ2 test and multivariate Logistic regression analysis of anxiety, depression and psychological resilience in young breast cancer patients influencing factors. Result Patients with adverse reactions had a significantly higher risk of anxiety, depression, and lower psychological resilience than those without adverse reactions （anxiety： OR ： 28.723; depression： OR = 23.954; low psychological resilience： OR - anxiety than patients who wish to receive relative support （OR 52.543）; hope to get doctors＇ supported patients were more prone to 257.035）; patients with a general degree of attention and no family history of breast cancer were more likely to have depression than patients with family history of breast cancer （OR = 9.310, 422.570）. Conclusion Anxiety and depression are common in young patients with breast cancer, and the level of psychological resilience is low. It is necessary to stxengthen health education and psychological intervention in clinical treatment to reduce the incidence of adverse reactions and give them social support. In order to alleviate the young patients with breast cancer adverse psychological problems.